IL6 and pancreatic neoplasm: Bazedoxifene has been investigated in vitro in combination with anti-interleukin 8 (IL-8), that is overexpressed in pancreatic cancer tissues and blood circulation, and is associated to metastasis and poor prognosis as well as IL-6 [76].